{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:06:43Z","timestamp":1760044003877},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.det.2016.02.001","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T23:47:31Z","timestamp":1467071251000},"page":"251-256","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Practice and Educational Gaps in Blistering Disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Nazanin","family":"Ehsani-Chimeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Peter","family":"Marinkovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2016.02.001_bib1","first-page":"491","article-title":"Diagnosis of autoimmune bullous skin diseases","volume":"54","author":"Zillikens","year":"2008","journal-title":"Clin Lab"},{"key":"10.1016\/j.det.2016.02.001_bib2","doi-asserted-by":"crossref","first-page":"175ra130","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.det.2016.02.001_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.md.0000076003.64510.00","article-title":"Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations","volume":"82","author":"Egan","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.det.2016.02.001_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1523-1747.ep12598050","article-title":"The epidermal-dermal junction","volume":"65","author":"Briggaman","year":"1975","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2016.02.001_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0190-9622(96)90604-0","article-title":"Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol\/L salt-split skin. Specificity, sensitivity, and practical considerations","volume":"35","author":"Lazarova","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.02.001_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0190-9622(92)70161-8","article-title":"Immunofluorescence on salt-split skin for the detection and differentiation of BMZ autoantibodies","volume":"27","author":"Gammon","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.02.001_bib7","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jaad.2004.01.011","article-title":"Pemphigus vulgaris\u2014a model for cutaneous autoimmunity","volume":"51","author":"Anhalt","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.02.001_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/08916934.2011.606444","article-title":"Pemphigus autoimmunity: hypotheses and realities","volume":"45","author":"Grando","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.det.2016.02.001_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.det.2016.02.001_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.det.2016.02.001_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0190-9622(97)70336-0","article-title":"Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol","volume":"36","author":"Hornschuh","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.02.001_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2133.1995.tb02498.x","article-title":"Bullous pemphigoid successfully controlled by tetracycline and nicotinamide","volume":"133","author":"Kolbach","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2016.02.001_bib13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cden.2013.06.002","article-title":"Pemphigus","volume":"57","author":"Santoro","year":"2013","journal-title":"Dent Clin North Am"},{"issue":"7","key":"10.1016\/j.det.2016.02.001_bib14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.1780240705","article-title":"Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy","volume":"24","author":"Gluck","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.det.2016.02.001_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaad.2015.04.038","article-title":"The role of adjuvant therapy in pemphigus: a systematic review and meta-analysis","volume":"73","author":"Atzmony","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.02.001_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jamadermatol.2014.2421","article-title":"First-line treatment of pemphigus vulgaris with a combination of rituximab and high-potency topical corticosteroids","volume":"151","author":"Ingen-Housz-Oro","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2016.02.001_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna","year":"2012","journal-title":"Clin Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863516300122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863516300122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T18:28:55Z","timestamp":1536604135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863516300122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0733863516300122"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2016.02.001","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practice and Educational Gaps in Blistering Disease","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2016.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}